Skip to main content

Longitude Venture Partners IV, L.P.

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Longitude Venture Partners IV, L.P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

LXEO Lexeo Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 9, 2023 (view filing)8:32 PM ETNov 72 daysEnright Patrick G and 3 others10% OwnerPPurchase+454.5K$11.00+$5.00M+21.5%2.57M after

VERA Vera Therapeutics, Inc.

10% Owner2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 8, 2023 (view filing)7:40 PM ETFeb 62 daysTammenoms Bakker Juliet and 4 others10% OwnerPPurchaseClass A Common Stock+1.71M$7.00+$12.0MNew position1.71M afterDuplicate filing
Apr 5, 2022 (view filing)7:24 AM ETFeb 1054 daysLateTammenoms Bakker Juliet and 2 others10% OwnerPPurchaseClass A Common Stock+333.3K$15.00+$5.00M+10.8%3.43M afterDuplicate filing